PROQR THERAPEUTICS EO-04 (0PQ) — Net Asset Momentum
PROQR THERAPEUTICS EO-04 (0PQ) recorded a net asset momentum of -44.2% as of December 2025, with net assets of €49.37 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 0PQ net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
PROQR THERAPEUTICS EO-04 Net Asset Momentum (2021–2025)
This chart tracks PROQR THERAPEUTICS EO-04's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -44.2%, with net assets of €49.37 Million EUR as of December 2025. For live market cap and overall valuation, see PROQR THERAPEUTICS EO-04 market cap and net worth.
Annual Net Asset History for PROQR THERAPEUTICS EO-04 (2021–2025)
The table below shows the complete annual net asset history for PROQR THERAPEUTICS EO-04 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check PROQR THERAPEUTICS EO-04 tangible equity quality to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €49.37 Million | €112.76 Million | €63.38 Million | ▼ -44.2% |
| 2024 | €88.56 Million | €167.96 Million | €79.40 Million | ▲ +114.0% |
| 2023 | €41.39 Million | €137.88 Million | €96.49 Million | ▼ -37.9% |
| 2022 | €66.68 Million | €171.32 Million | €104.64 Million | ▼ -41.1% |
| 2021 | €113.23 Million | €209.58 Million | €96.35 Million | — |